Charles River Laboratories International (CRL) Gross Profit (2009 - 2026)

Charles River Laboratories International's Gross Profit history runs 17 years deep, the most recent figure standing at $1.8 billion for Q4 2025.

• In Q4 2025, Gross Profit rose 88.68% year-over-year to $1.8 billion; the TTM figure through Dec 2025 stood at $4.4 billion (up 38.91% YoY), while the FY2025 annual figure was $3.6 billion, down 2.5% from the prior year.
• Gross Profit for Q4 2025 stood at $1.8 billion, up from $894.9 million in the prior quarter.
• The five-year high for Gross Profit was $2.7 billion in Q4 2023, with the low at $361.8 million in Q3 2023.
• The 5-year median for Gross Profit is $875.0 million (2022), against an average of $1.0 billion.
• The sharpest annual moves came in 2021 and 2024: Gross Profit jumped 169.19% in 2021, then sank 63.85% in 2024.
• Charles River Laboratories International's Gross Profit stood at $1.9 billion in 2021, then increased by 14.58% to $2.2 billion in 2022, then grew by 21.77% to $2.7 billion in 2023, then tumbled by 63.85% to $961.7 million in 2024, then jumped by 88.68% to $1.8 billion in 2025.
• Business Quant data shows CRL's Gross Profit at $1.8 billion in Q4 2025, $894.9 million in Q3 2025, and $889.0 million in Q2 2025.